158 related articles for article (PubMed ID: 1490578)
1. [Anti-Rho[D] antigen monoclonal antibodies. II. Serological characteristics of monoclonal IgG1 antibodies].
Olovnikova NI; Belkina EV; Lemeneva LN; Berkovskiĭ AL; Deriugina EI; Chertkov IL
Gematol Transfuziol; 1992; 37(9-10):5-9. PubMed ID: 1490578
[TBL] [Abstract][Full Text] [Related]
2. How do I manage Rh typing in obstetric patients?
Haspel RL; Westhoff CM
Transfusion; 2015 Mar; 55(3):470-4. PubMed ID: 25647404
[No Abstract] [Full Text] [Related]
3. Human monoclonal anti-D antibodies. I. Their production, serology, quantitation and potential use as blood grouping reagents.
Kumpel BM; Poole GD; Bradley BA
Br J Haematol; 1989 Jan; 71(1):125-9. PubMed ID: 2492817
[TBL] [Abstract][Full Text] [Related]
4. In vivo studies of monoclonal anti-D and the mechanism of immune suppression.
Kumpel BM
Transfus Clin Biol; 2002 Jan; 9(1):9-14. PubMed ID: 11889904
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of monoclonal anti-Rh antibodies as reagents for blood grouping and for the identification of red cell membrane components associated with Rh antigen activity.
Moore S; Green C; McGowan A
Rev Fr Transfus Immunohematol; 1988 Apr; 31(2):141-4. PubMed ID: 3145542
[No Abstract] [Full Text] [Related]
6. Monoclonal anti-D development programme.
Kumpel BM
Transpl Immunol; 2002 Aug; 10(2-3):199-204. PubMed ID: 12216950
[TBL] [Abstract][Full Text] [Related]
7. [Monoclonal antibodies to Rho(D)-antigen of the Rhesus system. Obtaining the EBV-transformed B-lymphoblastoid human cell lines secreting IgG-anti-D antibodies].
Deriugina EI; Olovnikova NI; Lemeneva LN; Belkina EV; Udalov GA; Chertkov IL
Gematol Transfuziol; 1991 Aug; 36(8):11-6. PubMed ID: 1661249
[TBL] [Abstract][Full Text] [Related]
8. Specificity and isotype of Rh specific antibodies produced by human B-cell lines established from alloimmunized Rh negative women.
Pasha RP; Bahrami ZS; Niroomanesh S; Ramzi F; Razavi AR; Shokri F
Transfus Apher Sci; 2005 Oct; 33(2):119-27. PubMed ID: 16103012
[TBL] [Abstract][Full Text] [Related]
9. [Obtention of a heterohybridoma for production of type IgM monoclonal antibodies against the D antigen of the Rh system].
León-González G; Cruz C
Invest Clin; 2007 Mar; 48(1):57-67. PubMed ID: 17432544
[TBL] [Abstract][Full Text] [Related]
10. Human Rh D monoclonal antibodies (BRAD-3 and BRAD-5) cause accelerated clearance of Rh D+ red blood cells and suppression of Rh D immunization in Rh D- volunteers.
Kumpel BM; Goodrick MJ; Pamphilon DH; Fraser ID; Poole GD; Morse C; Standen GR; Chapman GE; Thomas DP; Anstee DJ
Blood; 1995 Sep; 86(5):1701-9. PubMed ID: 7655002
[TBL] [Abstract][Full Text] [Related]
11. Phagocytosis by human monocytes of red cells sensitized with monoclonal IgG1 and IgG3 anti-D.
Hadley AG; Kumpel BM
Vox Sang; 1989; 57(2):150-1. PubMed ID: 2506695
[No Abstract] [Full Text] [Related]
12. Effect of producer cell line on functional activity of anti-D monoclonal antibodies destined for prevention of rhesus sensitization.
Olovnikova NI; Ershler MA; Belkina EV; Nikolaeva TL; Miterev GY
Bull Exp Biol Med; 2009 Apr; 147(4):448-52. PubMed ID: 19704946
[TBL] [Abstract][Full Text] [Related]
13. Cold agglutinin activity is common among human monoclonal IgM Rh system antibodies using the V4-34 heavy chain variable gene segment.
Thorpe SJ; Boult CE; Stevenson FK; Scott ML; Sutherland J; Spellerberg MB; Natvig JB; Thompson KM
Transfusion; 1997; 37(11-12):1111-6. PubMed ID: 9426632
[TBL] [Abstract][Full Text] [Related]
14. [The determination of the Rh factor with anti-D monoclonal antibodies on a flat surface].
Zavgorodniĭ GN; Pogodina TL; Pichugina MN
Gematol Transfuziol; 1993 Jan; 38(1):45-6. PubMed ID: 8020708
[No Abstract] [Full Text] [Related]
15. Serological studies of monoclonal RH antibodies with RH1 (D), RH2 (C), RH3 (E) and RH5 (e) variant RBCs.
Noizat-Pirenne F; Ansart-Pirenne H; Ménanteau C; Braddock D; Rouzaud AM; Klein MT; Patereau C; Rouger P; Le Pennec PY
Transfus Clin Biol; 2003 Oct; 10(5):319-23. PubMed ID: 14572547
[TBL] [Abstract][Full Text] [Related]
16. Human monoclonal anti-D with reactivity against category DVI cells used in blood grouping and determination of the incidence of the category DVI phenotype in the DU population.
Leader KA; Kumpel BM; Poole GD; Kirkwood JT; Merry AH; Bradley BA
Vox Sang; 1990; 58(2):106-11. PubMed ID: 2111059
[TBL] [Abstract][Full Text] [Related]
17. Production and characterization of human-human and human-mouse hybridomas secreting Rh(D)-specific monoclonal antibodies.
MacDonald G; Primrose S; Biggins K; Bowman JM; Berczi I; Friesen AD; Sehon AH
Scand J Immunol; 1987 May; 25(5):477-83. PubMed ID: 3035706
[TBL] [Abstract][Full Text] [Related]
18. Some observations on D antigen expression of D-positive and 'weak D-positive' red cells as assessed by flow cytometry.
Nelson M; Barrow LA; Popp H; Gibson J
Vox Sang; 1995; 69(2):152-4. PubMed ID: 8585204
[No Abstract] [Full Text] [Related]
19. Characterization of an IgG2, G2m(23) anti-Rh-D antibody.
Dugoujon JM; de Lange GG; Blancher A; Alie-Daram S; Marty Y
Vox Sang; 1989; 57(2):133-6. PubMed ID: 2506693
[TBL] [Abstract][Full Text] [Related]
20. [Remarks on routine use of the enzyme test LEN (LISS Enzyme) in immunohematological studies].
Walewska I; Seyfriedowa H; Michalewska B; Lenkiewicz B
Acta Haematol Pol; 1990; 21(2):219-24. PubMed ID: 2131721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
